Polymer-based macromolecular prodrugs
US11642414B2 · kind B2 · utility
1Cited by
22References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2022 |
| Grant date | May 9, 2023 |
| Priority date | — |
| Expiry date | Feb 11, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are macromolecular prodrugs in which camptothecin analogs are covalently bonded to polymers via ester bonds that are labile under physiological conditions. Also provided are methods of treating cancer, especially neuroblastoma with the macromolecular prodrugs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.